A new process for synthesising anti-inflammatory drugs such as
ibuprofen could offer an environmentally friendly means of avoiding
the 50 per cent waste seen with current methods of synthesis.
The fine chemicals division of Japanese contract manufacturer Daiso
has taken out a license to a highly-selective technology used to
synthesise chiral molecules.
The UK subsidiary of Nicholas Piramal (NPIL) is working on a new
catalyst-based racemisation technology called SCRAM that delivers
significantly improved process yields in the production of chiral
amines and alcohols, cutting cost...
Warwick Analytical Services has made available a service that
allows the investigation and measurement of the optical activity of
samples with an accuracy of +/- 0.002 degrees for optical rotations
of less than 1 degree.
Fine chemicals company Rohner is to work together with
Switzerland's Solvias on the provision of development and
manufacturing services for complex active pharmaceutical
ingredients (APIs).
Germany's BASF has entered into a collaboration with Solvias of
Switzerland that will see the two companies combine their expertise
in the development and manufacture of chiral intermediates for the
life science industry.
BioCatalytics has expanded its product line of enzymes for chemical
synthesis with the addition of new ketoreductases (KRED) enzymes
for the stereoselective reduction of ketones.
The US market for chiral technologies - used to make single isomers
of compounds - will grow by an estimated 8.8 per cent a year to
reach a value of $1.8 billion (€1.4bn) in 2008, according to
soon-to-be-released market research.
Bayer Chemicals became a separate legal entity from the rest of the
Bayer group just over one month ago, having operated as a virtual
company since the middle of 2002. The company gave its first press
conference at the CPhI meeting...
